| Product Code: ETC11383566 | Publication Date: Apr 2025 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Bhawna Singh | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
The India anti-tuberculosis drugs market import shipment witnessed a substantial decline with a CAGR of -84.7% from 2020 to 2024. However, a notable positive momentum was observed with a growth rate of 200.0% between 2023 and 2024, indicating a potential turnaround or stabilization in the market after a period of sharp contraction.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 India Anti Tuberculosis Drugs Market Overview |
3.1 India Country Macro Economic Indicators |
3.2 India Anti Tuberculosis Drugs Market Revenues & Volume, 2021 & 2031F |
3.3 India Anti Tuberculosis Drugs Market - Industry Life Cycle |
3.4 India Anti Tuberculosis Drugs Market - Porter's Five Forces |
3.5 India Anti Tuberculosis Drugs Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.6 India Anti Tuberculosis Drugs Market Revenues & Volume Share, By Formulation, 2021 & 2031F |
3.7 India Anti Tuberculosis Drugs Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
3.8 India Anti Tuberculosis Drugs Market Revenues & Volume Share, By Patient Type, 2021 & 2031F |
4 India Anti Tuberculosis Drugs Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of tuberculosis in India |
4.2.2 Government initiatives to control tuberculosis |
4.2.3 Rising awareness about the importance of early diagnosis and treatment |
4.3 Market Restraints |
4.3.1 High cost of anti-tuberculosis drugs |
4.3.2 Limited access to healthcare facilities in rural areas |
4.3.3 Emergence of drug-resistant strains of tuberculosis |
5 India Anti Tuberculosis Drugs Market Trends |
6 India Anti Tuberculosis Drugs Market, By Types |
6.1 India Anti Tuberculosis Drugs Market, By Drug Class |
6.1.1 Overview and Analysis |
6.1.2 India Anti Tuberculosis Drugs Market Revenues & Volume, By Drug Class, 2021 - 2031F |
6.1.3 India Anti Tuberculosis Drugs Market Revenues & Volume, By First-Line, 2021 - 2031F |
6.1.4 India Anti Tuberculosis Drugs Market Revenues & Volume, By Second-Line, 2021 - 2031F |
6.2 India Anti Tuberculosis Drugs Market, By Formulation |
6.2.1 Overview and Analysis |
6.2.2 India Anti Tuberculosis Drugs Market Revenues & Volume, By Tablet, 2021 - 2031F |
6.2.3 India Anti Tuberculosis Drugs Market Revenues & Volume, By Injectable, 2021 - 2031F |
6.3 India Anti Tuberculosis Drugs Market, By Distribution Channel |
6.3.1 Overview and Analysis |
6.3.2 India Anti Tuberculosis Drugs Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.3.3 India Anti Tuberculosis Drugs Market Revenues & Volume, By Retail, 2021 - 2031F |
6.3.4 India Anti Tuberculosis Drugs Market Revenues & Volume, By Pharmacies, 2021 - 2031F |
6.3.5 India Anti Tuberculosis Drugs Market Revenues & Volume, By Online, 2021 - 2031F |
6.4 India Anti Tuberculosis Drugs Market, By Patient Type |
6.4.1 Overview and Analysis |
6.4.2 India Anti Tuberculosis Drugs Market Revenues & Volume, By Adults, 2021 - 2031F |
6.4.3 India Anti Tuberculosis Drugs Market Revenues & Volume, By Pediatric, 2021 - 2031F |
7 India Anti Tuberculosis Drugs Market Import-Export Trade Statistics |
7.1 India Anti Tuberculosis Drugs Market Export to Major Countries |
7.2 India Anti Tuberculosis Drugs Market Imports from Major Countries |
8 India Anti Tuberculosis Drugs Market Key Performance Indicators |
8.1 Percentage of population screened for tuberculosis |
8.2 Number of government-funded tuberculosis treatment programs |
8.3 Rate of successful treatment outcomes for tuberculosis patients |
9 India Anti Tuberculosis Drugs Market - Opportunity Assessment |
9.1 India Anti Tuberculosis Drugs Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.2 India Anti Tuberculosis Drugs Market Opportunity Assessment, By Formulation, 2021 & 2031F |
9.3 India Anti Tuberculosis Drugs Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
9.4 India Anti Tuberculosis Drugs Market Opportunity Assessment, By Patient Type, 2021 & 2031F |
10 India Anti Tuberculosis Drugs Market - Competitive Landscape |
10.1 India Anti Tuberculosis Drugs Market Revenue Share, By Companies, 2024 |
10.2 India Anti Tuberculosis Drugs Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here